title: Experimental infectious respiratory disease in groups of calves: lobar distribution, variance, and sample-size requirements for vaccine evaluation.
abstract: The distribution and variance of respiratory disease produced with aerosols of bovine herpesvirus 1 (BHV-1) and Mannheimia haemolytica in control (183 calves in 44 experiments) and vaccinated calves were studied in experiments conducted at the Animal Diseases Research Institute, Lethbridge, Alberta, from 1975 to 1989. All calves had been born and raised at this institute and exposed similarly for 5 min by means of a face mask to viral and bacterial aerosols produced by a Collison atomizer (particles < 3 microm in diameter). We summarized the macroscopic pathological responses of pneumonia (main end point), tonsillitis, tracheitis, and other microbiologic and experimental variables. We also summarized the lobar distribution of pneumonia in 202 control and 192 vaccinated calves with this disease model and in calves similarly exposed to parainfluenza 3 virus/M. haemolytica or BHV-1/Pasteurella multocida. Pneumonia in control calves began in ventral tissues of all lobes, with lobar preferences, and progressed dorsally, the dorsal parts of both large caudal lobes being least affected. A high variance of pneumonia was evident within and among experiments. From the magnitude of variance observed in the control groups, the number of calves per group required in vaccine-challenge studies using this BHV-1/M. haemolytica disease model was estimated. Such estimates are required for any disease model used in vaccine-challenge studies.
authors.affiliation: Health Canada, Population and Public Health Branch, Animal Diseases Research Institute, Canadian Food Inspection Agency, PO Box 640, Lethbridge, Alberta T1J 3Z4. jerichok@inspection.gc.ca
authors.forename: K W F
authors.initials: KW
authors.lastname: Jericho
authors.forename: G C
authors.initials: GC
authors.lastname: Kozub
mesh_terms: D000336:Aerosols; D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D006566:Herpesviridae Infections / Q000473:pathology / Q000517:prevention & control / Q000662:veterinary*; D007242:Herpesvirus 1, Bovine / Q000276:immunology*; D008168:Lung / Q000382:microbiology / Q000473:pathology / Q000821:virology; D016978:Mannheimia haemolytica / Q000276:immunology*; D010326:Pasteurella Infections / Q000473:pathology / Q000517:prevention & control / Q000662:veterinary*; D011897:Random Allocation; D012141:Respiratory Tract Infections / Q000473:pathology / Q000517:prevention & control / Q000662:veterinary; D018401:Sample Size; D013047:Specific Pathogen-Free Organisms; D014611:Vaccination / Q000662:veterinary*
chemical_list: D000336:Aerosols